Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -121,994 | -102,400 | -101,215 | -1,028,857 | -164,272 |
| Depreciation Amortization | 172,020 | 115,595 | 60,312 | 1,084,319 | 193,008 |
| Income taxes - deferred | -512 | -1,013 | -1,007 | -10,119 | 1,827 |
| Accounts receivable | -56,233 | -103,086 | -30,072 | -46,259 | -61,410 |
| Accounts payable and accrued liabilities | 165,183 | 98,048 | 58,633 | 43,538 | 38,258 |
| Other Working Capital | 84,012 | -36,194 | -1,840 | -56,012 | -34,540 |
| Other Operating Activity | 97,273 | 148,876 | 45,998 | 223,926 | 190,602 |
| Operating Cash Flow | $339,749 | $119,826 | $30,809 | $210,536 | $163,473 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 230,213 | 236,633 | -2,758 | -259,210 | -254,469 |
| PPE Investments | -103,413 | -73,516 | -31,174 | -180,989 | -144,673 |
| Purchase Of Investment | -51,064 | -775 | N/A | -1,731 | -916 |
| Other Investing Activity | 28,268 | 28,116 | -505 | -225 | -225 |
| Investing Cash Flow | $104,004 | $190,458 | $-34,437 | $-442,155 | $-400,283 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | 266,750 | 266,750 |
| Debt Repayment | -249,172 | -249,172 | -249,172 | N/A | 0 |
| Common Stock Issued | 16,113 | 15,904 | -422 | 32,878 | 20,169 |
| Other Financing Activity | -29,158 | -27,417 | -6,577 | -67,754 | -65,544 |
| Financing Cash Flow | $-262,217 | $-260,685 | $-256,171 | $231,874 | $221,375 |
| Exchange Rate Effect | 865 | 864 | 290 | -3,294 | 427 |
| Beginning Cash Position | 606,636 | 606,636 | 606,636 | 609,675 | 609,675 |
| End Cash Position | 789,037 | 657,099 | 347,127 | 606,636 | 594,667 |
| Net Cash Flow | $182,401 | $50,463 | $-259,509 | $-3,039 | $-15,008 |
| Free Cash Flow | |||||
| Operating Cash Flow | 339,749 | 119,826 | 30,809 | 210,536 | 163,473 |
| Capital Expenditure | -103,413 | -73,516 | -31,174 | -180,989 | -144,673 |
| Free Cash Flow | 236,336 | 46,310 | -365 | 29,547 | 18,800 |